Hospital Relationships With Direct-to-Consumer Screening Companies
The debate over direct-to-consumer (DTC) screening companies intensified recently as Public Citizen, a consumer advocacy organization, sent letters to 20 hospitals on Jun 19, 2014, urging their leadership to sever business relationships with HealthFair, a prominent DTC screening company. Public Citi...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2014-09, Vol.312 (9), p.891-892 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The debate over direct-to-consumer (DTC) screening companies intensified recently as Public Citizen, a consumer advocacy organization, sent letters to 20 hospitals on Jun 19, 2014, urging their leadership to sever business relationships with HealthFair, a prominent DTC screening company. Public Citizen states that HealthFair's "heavily promoted, community-wide cardiovascular health screening programs are unethical and are much more likely to do harm than good," and they cite peer-reviewed evidence in support of their claims. Here, Wallace et al investigate the net benefit with the tests and treatments of hospitals and DTC screening companies. |
---|---|
ISSN: | 0098-7484 1538-3598 |
DOI: | 10.1001/jama.2014.9500 |